Andersons pediatric cardiology 1590

dystrophies.PediatrCardiol.2005;26(1):66–72.
226.MarkhamLW,MichelfelderEC,BorderWL,et
al.Abnormalitiesofdiastolicfunctionprecede
dilatedcardiomyopathywithduchennemuscular
dystrophy.JAmSocEchocardiogr.
2006;19(7):865–871.
227.OgataH,NakataniS,IshikawaY,etal.
Myocardialstrainchangesinduchennemuscular
dystrophywithoutoverrtcardiomyopathy.IntJ
Cardiol.2007;115(2):190–195.
228.MatsumuraT,SaitoT,FujimuraH,ShinnoS.
CardiactroponinIforaccurateevaluationof
cardiacstatusinmyopathicpatients.BrainDev.
2007[Epubaheadofprint].
229.RamaciottiC,HeisteinLC,CourseyM,etal.
Leftventricularfunctionandresponseto
enalaprilinpatientswithduchennemuscular
dystrophyduringtheseconddecadeoflife.AmJ
Cardiol.2006;98(6):825–827.
230.DubocD,MeuneC,LereboursG,etal.Effectof
perindoprilontheonsetandprogressionofleft
ventriculardysfunctioninduchennemuscular
dystrophy.JAmCollCardiol.2005;45(6):855–
857.
231.KajimotoH,IshigakiK,OkumuraK,etal.Betablockertherapyforcardiacdysfunctionin
patientswithmusculardystrophy.CircJ.


2006;70(8):991–994.
232.EvansT.Cardiacabnormalitiesassociatedwith
hereditaryneuromusculardiseases.SymonsC,

EvansT.SpecificHeartMuscleDisease.PSG
Wright:Boston;1983:46–61.
233.SanyalSK,JohnsonWW.Cardiacconduction
abnormalitiesinchildrenwithDuchenne's
progressivemusculardystrophy:
electrocardiographicfeaturesandmorphologic
correlates.Circulation.1982;66:853–863.
234.Shimizu-MotohashiY,MiyatakeS,KomakiH,
TakedaS,AokiY.Recentadvancesin
innovativetherapeuticapproachesforduchenne
musculardystrophy:fromdiscoverytoclinical
trials.AmJTranslRes.2016;8(6):2471–2489.
235.BonuccelliG,SotgiaF,CapozzaF,etal.
LocalizedtreatnebtwithanovelFDA-approved
proteasomeinhibitorblocksthedegradationof
dystrophin-associatedproteinsinmdxmice.Cell
Cycle.2007;6(10):1242–1248.
236.TownsendD,YasudaS,MetzgerJ.
Cardiomyopathyofduchennemuscular
dystrophy:pathogenesisandprospectof
membranesealantsasanewtherapeutic
approach.ExpertRevCardiovascTher.
2007;5(1):99–109.
237.QuennevilleSP,ChapdelaineP,SkukD,etal.


Autologoustransplantationofmuscleprecursor
cellsmodifiedwithalentivirusformuscular
dystrophy:humancellsandrimatemodels.Mol
Ther.2007;15(2):431–438.

238.BenYaouR,BecaneHM,DemayL,etal.
Autosomaldominantlimb-girdlemuscular
dystrophyassociatedwithconductiondefects
(LGMD1B):adescriptionof8newfamilies
withtheLMNAgenemutations.RevNeurol
(Paris).2005;161(1):42–54.
239.GaulC,DeschauerM,TempelmannC,etal.
Cardiacinvolvementinlimb-girdlemuscular
dystrophy2i.JNeurol.2006;253(10):1317–
1322.
240.BrookJD,McCurrachME,HarleyHG,etal.
Molecularbasisofmyotonicdystrophy:
expansionofatrinucleotide(CTG)repeatatthe
3’endofatranscriptencodingaproteinkinase
familymember.Cell.1992;68(4):799–808.
241.NishiokaSA,MartinelliFilhoM,MarieS,Zatz
M,CostaR.Myotonicdystrophyandheart
disease;behaviorofarrhythmiceventsand
conductiondisturbances.ArqBrasCardiol.
2005;84(4):330–336.
242.BharatiS,BumpFT,BauernfiendR,LevM.
Dystrophicamyotonia.Correlative
electrocardiographic,electrophysiologicand